Tbx3は,誘導された多能幹幹細胞の生殖能力を改善する
Jianyong Han1, Ping Yuan, Henry Yang
1Stem Cell and Developmental Biology, Genome Institute of Singapore, 138672, Singapore.
Nature
|February 9, 2010
まとめ
転写因子Tbx3をOct4,Sox2,Klf4 (OSK) に加えると,誘発性多能幹細胞 (iPS) の質が著しく向上する. これらの改善されたOSKT iPS細胞は,優越した生殖線伝達と生殖組織への貢献を示しています.
科学分野:
- 幹細胞生物学 幹細胞生物学
- 生殖生物学 生殖生物学
- 遺伝学 遺伝学とは
背景:
- 誘発性多能幹細胞 (iPS) は,胚性幹細胞 (ESC) に対する有望な代替手段を提供している.
- 最小限のOct4,Sox2,Klf4 (OSK) 因子は,体細胞をiPS細胞に再プログラムすることができます.
- iPS細胞の質,特に生殖線の可能性を評価するには,遺伝子発現を超えて厳格な評価が必要です.
研究 の 目的:
- 転写因子Tbx3がiPS細胞の質と再プログラム効率に与える影響を調査する.
- Tbx3-改変されたiPS細胞が,生殖線伝播とキメアリズムに与える貢献を評価する.
- Tbx3が多能性と再プログラミングに影響を与える分子メカニズムを理解する.
主な方法:
- Oct4,Sox2,Klf4 (OSK) を使ってTbx3 (OSKT) を含むまたは含まないiPS細胞を生成する.
- テトラプロイド補充によるキメアリズムと生殖線伝播に対するiPS細胞の貢献度評価.
- ESCにおけるTbx3結合部位を特定するために,全ゲノムクロマチン免疫プレシピテーションシーケンシング (ChIP-seq) を用いる.
主要な成果:
- Tbx3は,OSKT iPS細胞と呼ばれるiPS細胞の質を大幅に改善しました.
- OSKT iPS細胞は,性腺に優越した生殖細胞の貢献と,より高い生殖線伝播率を示した.
- グローバル遺伝子発現プロファイリングでは,OSKとOSKTのiPS細胞を区別できず,質的な違いが示唆されました.
結論:
- Tbx3は,iPS細胞の発達の可能性と品質を高める上で重要な役割を果たしています.
- 異なる再プログラム方法によって生成されたiPS細胞の間には,本質的な質的差異が存在します.
- in vivoの機能性アッセイを含むiPS細胞の厳格な特徴づけは不可欠です.
関連する概念動画
Induced Pluripotent Stem Cells
22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Methods of Nuclear Reprogramming
1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K


